Shiri Kalet-Litman

869 total citations
7 papers, 668 citations indexed

About

Shiri Kalet-Litman is a scholar working on Cell Biology, Physiology and Surgery. According to data from OpenAlex, Shiri Kalet-Litman has authored 7 papers receiving a total of 668 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Cell Biology, 4 papers in Physiology and 3 papers in Surgery. Recurrent topics in Shiri Kalet-Litman's work include Hemoglobin structure and function (6 papers), Heme Oxygenase-1 and Carbon Monoxide (3 papers) and Nitric Oxide and Endothelin Effects (3 papers). Shiri Kalet-Litman is often cited by papers focused on Hemoglobin structure and function (6 papers), Heme Oxygenase-1 and Carbon Monoxide (3 papers) and Nitric Oxide and Endothelin Effects (3 papers). Shiri Kalet-Litman collaborates with scholars based in Israel and United States. Shiri Kalet-Litman's co-authors include Rachel Miller‐Lotan, Andrew P. Levy, Rabea Asleh, Julia Guetta, Roy Asaf, Shany Blum, Nina S. Levy, Jonia Alshiek, Farid Nakhoul and Hagit Goldenstein and has published in prestigious journals such as Circulation Research, Diabetes and Arteriosclerosis Thrombosis and Vascular Biology.

In The Last Decade

Shiri Kalet-Litman

7 papers receiving 654 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shiri Kalet-Litman Israel 7 353 195 181 157 137 7 668
Julia Guetta Israel 8 413 1.2× 228 1.2× 176 1.0× 182 1.2× 129 0.9× 9 723
Roy Asaf Israel 9 298 0.8× 177 0.9× 148 0.8× 125 0.8× 123 0.9× 9 580
Yefim Anbinder Israel 8 252 0.7× 621 3.2× 145 0.8× 125 0.8× 110 0.8× 9 1.1k
Yu Ishimoto Japan 10 138 0.4× 346 1.8× 44 0.2× 85 0.5× 100 0.7× 21 880
Diana Choi Canada 12 100 0.3× 220 1.1× 31 0.2× 86 0.5× 219 1.6× 19 546
Matthew J. Wither United States 18 90 0.3× 342 1.8× 106 0.6× 315 2.0× 42 0.3× 24 919
Xiaomin Pan United States 10 69 0.2× 164 0.8× 46 0.3× 67 0.4× 88 0.6× 16 574
Pablo J. Giraudi Italy 14 73 0.2× 288 1.5× 194 1.1× 57 0.4× 84 0.6× 36 652
Shabnam Pooya United States 10 58 0.2× 363 1.9× 73 0.4× 90 0.6× 79 0.6× 12 627
Diana Ensenat United States 10 118 0.3× 460 2.4× 53 0.3× 96 0.6× 60 0.4× 14 662

Countries citing papers authored by Shiri Kalet-Litman

Since Specialization
Citations

This map shows the geographic impact of Shiri Kalet-Litman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shiri Kalet-Litman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shiri Kalet-Litman more than expected).

Fields of papers citing papers by Shiri Kalet-Litman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shiri Kalet-Litman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shiri Kalet-Litman. The network helps show where Shiri Kalet-Litman may publish in the future.

Co-authorship network of co-authors of Shiri Kalet-Litman

This figure shows the co-authorship network connecting the top 25 collaborators of Shiri Kalet-Litman. A scholar is included among the top collaborators of Shiri Kalet-Litman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shiri Kalet-Litman. Shiri Kalet-Litman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
1.
Asaf, Roy, Shany Blum, Ariel Roguin, et al.. (2009). Haptoglobin genotype is a determinant of survival and cardiac remodeling after myocardial infarction in diabetic mice. Cardiovascular Diabetology. 8(1). 29–29. 13 indexed citations
2.
Levy, Andrew P., Rabea Asleh, Shany Blum, et al.. (2009). Haptoglobin: Basic and Clinical Aspects. Antioxidants and Redox Signaling. 12(2). 293–304. 222 indexed citations
3.
Asleh, Rabea, Shany Blum, Shiri Kalet-Litman, et al.. (2008). Correction of HDL Dysfunction in Individuals With Diabetes and the Haptoglobin 2-2 Genotype. Diabetes. 57(10). 2794–2800. 107 indexed citations
4.
Levy, Andrew P., Joanne E. Levy, Shiri Kalet-Litman, et al.. (2006). Haptoglobin Genotype Is a Determinant of Iron, Lipid Peroxidation, and Macrophage Accumulation in the Atherosclerotic Plaque. Arteriosclerosis Thrombosis and Vascular Biology. 27(1). 134–140. 121 indexed citations
5.
Miller‐Lotan, Rachel, Shiri Kalet-Litman, Farid Nakhoul, et al.. (2005). Increased renal hypertrophy in diabetic mice genetically modified at the haptoglobin locus. Diabetes/Metabolism Research and Reviews. 21(4). 332–337. 14 indexed citations
6.
Asleh, Rabea, Julia Guetta, Shiri Kalet-Litman, Rachel Miller‐Lotan, & Andrew P. Levy. (2005). Haptoglobin Genotype– and Diabetes-Dependent Differences in Iron-Mediated Oxidative Stress In Vitro and In Vivo. Circulation Research. 96(4). 435–441. 166 indexed citations
7.
Madar, Zecharia, Shiri Kalet-Litman, & Aliza H. Stark. (2004). Inducible Nitric Oxide Synthase Activity and Expression in Liver and Hepatocytes of Diabetic Rats. Pharmacology. 73(2). 106–112. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026